Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1524219

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1524219

U.S. Dialysis Services Market - By Type (Hemodialysis, Peritoneal Dialysis), By Service (Acute Dialysis, Chronic Dialysis), By End-use (In-center Dialysis, Home Dialysis) & Forecast, 2024 - 2032

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3250
PDF & Excel (Multi User License)
USD 3750
PDF & Excel (Enterprise User License)
USD 5750

Add to Cart

U.S. Dialysis Services Market will exhibit over 4% CAGR from 2024 to 2032, ushered by the escalating integration of telehealth services. The integration of telehealth services in the U.S. has revolutionized patient care by enabling remote monitoring and management. This advancement enhances accessibility to critical healthcare services for dialysis patients, regardless of geographical location or mobility limitations.

According to a cross-sectional study of adults with healthcare visits Patient Characteristics and Telemedicine Use in the U.S., 2022 published by JAMA Network Open, many patients, including those with the greatest care needs, opted for telemedicine even when in-person visits were available. These findings suggest that telemedicine remains a valued care delivery option for patients, supporting its continued use.

Telehealth solutions facilitate real-time monitoring of vital signs, medication adherence, and treatment progress, leading to proactive interventions and improved health outcomes. By reducing the need for frequent in-person visits while maintaining high-quality care standards, telehealth improves patient convenience as well as optimizes healthcare resource utilization in the management of chronic kidney diseases.

The overall U.S. dialysis services industry is categorized based on type, service, end-use, and region.

The peritoneal dialysis segment will procure a noticeable U.S. dialysis services market share by 2032. The demand for U.S. Dialysis Services is increasing significantly, particularly in the peritoneal dialysis PD segment, followed closely by Hemodialysis HD. PDs appeal lies in its flexibility, allowing patients to perform treatments at home, which is convenient and offers greater autonomy over treatment schedules. This method is increasingly preferred by patients seeking a less restrictive lifestyle compared to frequent clinic visits required for home dialysis. Moreover, technological advancements in PD systems have improved ease of use and reliability, boosting its popularity.

On the other hand, home dialysis remains crucial due to its effectiveness in managing severe kidney dysfunction and acute conditions. Both segments benefit from rising chronic kidney disease CKD prevalence and aging demographics, driving overall growth in the dialysis services market as healthcare providers strive to meet diverse patient needs with advanced treatment options.

The home dialysis segment will indicate a noteworthy CAGR through 2032. The U.S. dialysis services market is increasing notably in the home dialysis segment, followed closely by the In-center Dialysis segment. Home Dialysis, including options such as peritoneal dialysis PD and home hemodialysis HHD, offers patients greater flexibility, convenience, and a sense of independence by allowing them to manage treatments in familiar surroundings. This segments growth is driven by technological advancements making home dialysis safer and easier to administer, coupled with patient preference for reducing travel and treatment time at clinics.

Meanwhile, in-center dialysis remains crucial for patients requiring intensive medical supervision and complex care, ensuring consistent access to specialized equipment and trained healthcare professionals. Both segments respond to increasing rates of chronic kidney disease CKD and ESRD, reflecting a broader trend toward personalized care models that enhance patient outcomes and quality of life.

Product Code: 9131

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising number of end stage renal diseases (ESRD) patients
      • 3.2.1.2 Favourable reimbursement scenario available for dialysis treatment
      • 3.2.1.3 Increasing awareness and education
      • 3.2.1.4 Rise in R&D investment
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Complications in the treatment
      • 3.2.2.2 High treatment costs
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Reimbursement scenario
  • 3.7 Future market trends
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Value chain analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Hemodialysis
  • 5.3 Peritoneal dialysis

Chapter 6 Market Estimates and Forecast, By Service, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Acute dialysis
  • 6.3 Chronic dialysis

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 In-center dialysis
  • 7.3 Home dialysis

Chapter 8 Market Estimates and Forecast, By Zone, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 East North Central
    • 8.2.1 Illinois
    • 8.2.2 Indiana
    • 8.2.3 Michigan
    • 8.2.4 Ohio
    • 8.2.5 Wisconsin
  • 8.3 West South Central
    • 8.3.1 Arkansas
    • 8.3.2 Louisiana
    • 8.3.3 Oklahoma
    • 8.3.4 Texas
  • 8.4 South Atlantic
    • 8.4.1 Delaware
    • 8.4.2 Florida
    • 8.4.3 Georgia
    • 8.4.4 Maryland
    • 8.4.5 North Carolina
    • 8.4.6 South Carolina
    • 8.4.7 Virginia
    • 8.4.8 West Virginia
    • 8.4.9 Washington, D.C.
  • 8.5 North East
    • 8.5.1 Connecticut
    • 8.5.2 Maine
    • 8.5.3 Massachusetts
    • 8.5.4 New Hampshire
    • 8.5.5 Rhode Island
    • 8.5.6 Vermont
    • 8.5.7 New Jersey
    • 8.5.8 New York
    • 8.5.9 Pennsylvania
  • 8.6 East South Central
    • 8.6.1 Alabama
    • 8.6.2 Kentucky
    • 8.6.3 Mississippi
    • 8.6.4 Tennessee
  • 8.7 Pacific Central
    • 8.7.1 Alaska
    • 8.7.2 California
    • 8.7.3 Hawaii
    • 8.7.4 Oregon
    • 8.7.5 Washington
  • 8.8 Mountain States
    • 8.8.1 Arizona
    • 8.8.2 Colorado
    • 8.8.3 Utah
    • 8.8.4 Nevada
    • 8.8.5 New Mexico
    • 8.8.6 Idaho
    • 8.8.7 Montana
    • 8.8.8 Wyoming

Chapter 9 Company Profiles

  • 9.1 Baxter International Inc.
  • 9.2 Centers for Dialysis Care
  • 9.3 DaVita Inc.
  • 9.4 Dialysis Clinic, Inc.
  • 9.5 Fresenius Medical Care
  • 9.6 Innovative Renal Care
  • 9.7 Rogosin Institute
  • 9.8 Sanderling Renal Services
  • 9.9 Satellite Healthcare
  • 9.10 U.S. Renal Care, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!